- Home
- EPSN vs KOD Comparison
EPSN vs KOD Comparison
Compare EPSN & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPSN
- KOD
- Stock Information
- Founded
- EPSN 2005
- KOD 2009
- Country
- EPSN Canada
- KOD United States
- Employees
- EPSN N/A
- KOD N/A
- Industry
- EPSN Oil & Gas Production
- KOD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- EPSN Energy
- KOD Health Care
- Exchange
- EPSN Nasdaq
- KOD Nasdaq
- Market Cap
- EPSN 129.8M
- KOD 186.3M
- IPO Year
- EPSN N/A
- KOD 2018
- Fundamental
- Price
- EPSN $5.85
- KOD $8.72
- Analyst Decision
- EPSN Strong Buy
- KOD Hold
- Analyst Count
- EPSN 1
- KOD 5
- Target Price
- EPSN $7.00
- KOD $6.80
- AVG Volume (30 Days)
- EPSN 25.3K
- KOD 473.7K
- Earning Date
- EPSN 11-06-2024
- KOD 11-14-2024
- Dividend Yield
- EPSN 4.33%
- KOD N/A
- EPS Growth
- EPSN N/A
- KOD N/A
- EPS
- EPSN 0.24
- KOD N/A
- Revenue
- EPSN $31,145,315.00
- KOD N/A
- Revenue This Year
- EPSN N/A
- KOD N/A
- Revenue Next Year
- EPSN $15.65
- KOD N/A
- P/E Ratio
- EPSN $24.21
- KOD N/A
- Revenue Growth
- EPSN N/A
- KOD N/A
- 52 Week Low
- EPSN $4.70
- KOD $2.19
- 52 Week High
- EPSN $6.20
- KOD $11.60
- Technical
- Relative Strength Index (RSI)
- EPSN 50.47
- KOD 64.72
- Support Level
- EPSN $5.67
- KOD $8.03
- Resistance Level
- EPSN $6.00
- KOD $9.55
- Average True Range (ATR)
- EPSN 0.22
- KOD 0.89
- MACD
- EPSN -0.01
- KOD -0.08
- Stochastic Oscillator
- EPSN 53.12
- KOD 36.51
About EPSN Epsilon Energy Ltd. Common Share
Epsilon Energy Ltd is engaged in the acquisition, development, gathering, and production of natural gas and oil reserves. The operating segments of the company include Upstream segment activities including acquisition, development, and production of natural gas reserves on properties within the United States. The Gas Gathering segment partners with two other companies to operate a natural gas gathering system, and the corporate segment activities include corporate listing and governance functions of the corporation. The company generates revenue from the sale of crude oil and natural gas.
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is KSI-301, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD.